Skip to main content

Table 5 Impact of individual-level uncertainty on the relative risk of PRS deciles on lung cancer risk in stratified analyses by gender, lung cancer histology, and smoking status

From: Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification

 

Subgroups

90th vs. 10th (PRS CI-based)

90th vs. 10th (PRS mean-based)

 

OR (95% CI)

P-value

n

OR (95% CI)

P-value

n

Gender

Male

2.63 (1.91, 3.62)

3.09e−09

772

2.06 (1.79, 2.37)

2.80e−24

3731

Female

2.88 (1.92, 4.32)

2.83e−07

484

2.54 (2.12, 3.04)

3.39e−24

2281

Histology

NSCLC

2.84 (2.19, 3.70)

6.14e−15

1117

2.31 (2.06, 2.60)

3.53e−45

5199

ADC

3.70 (2.69, 5.09)

8.71e−16

842

2.76 (2.39, 3.18)

9.60e−45

3874

SCC

2.11 (1.45, 3.07)

8.93e−05

752

1.71 (1.45, 2.02)

2.61e−10

3406

SCLC

2.53 (1.43, 4.46)

1.38e−03

630

1.86 (1.47, 2.36)

2.01e−07

2906

Smoking

Never

4.22 (2.25, 7.92)

7.25e−06

223

2.63 (2.02, 3.43)

9.94e−13

1125

Former

2.25 (1.54, 3.28)

2.43e−05

494

2.18 (1.83, 2.59)

1.19e−18

2280

Current

2.74 (1.84, 4.10)

8.28e−07

539

2.13 (1.79, 2.52)

3.88e−18

2607

  1. For the PRS CI-based approach, the stratified analyses were only conducted in the individuals that can be identified with certainty. The detailed sample sizes that were included in each analysis were noted in column n. Odds ratio (OR) and 95% confidence intervals (CI) are shown. NSCLC, non-small cell lung cancer; ADC, adenocarcinoma, SCC, squamous cell carcinoma; SCLC, small cell lung cancer